Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Kamele in Dubai

Please use this image only in connection with this press release.

© LMU

© LMU
May 3 2021

MERS coronavirus: Vaccine development is going into the next round

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional

Malariaimpfung

Please use this image only in connection with this press release.

© Universität Tübingen / Paul Mehnert

© Universität Tübingen / Paul Mehnert
May 4 2021

Tübingen study raises hope for effective malaria vaccine

At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel

Feb 2021
J Hepatol

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

Autoren
Cornberg M et al.
Jan 2021
Front Immunol

Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens

Autoren
Fathi A
Addo MM
Dahlke C
May 2021
Nat Commun

Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

Autoren
Sulyok Z et al.
Coronaviren als Bedrohung

© Tumisu auf Pixabay

© Tumisu auf Pixabay
Mar 29 2021

Will COVID-19 vaccines need to be adapted regularly?

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent

Dec 2020
Proc Natl Acad Sci U S A

A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine

Autoren
Hörner C et al.
Dec 2020
Front Immunol

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity

Autoren
Agnolon V et al.
Christoph Lange

© FZ Borstel

© FZ Borstel
Mar 22 2021

The clock is ticking! Three people dying of tuberculosis every minute

The clock is ticking: The motto of this year's World Tuberculosis Day makes clear that tuberculosis still remains one of the world's deadliest infections. In particular, people in poorer countries are

Impfstoffe

© fernando zhiminaicela auf Pixabay

© fernando zhiminaicela auf Pixabay
Mar 2 2021

New consortium coordinates research on COVID-19 vaccines in Europe

The need for vaccine studies continues to be high, as many questions remain unanswered about the safety, efficacy and possibly necessary adaptation of vaccines to emerging virus variants. In order to

Pagination

Previous page ‹‹
Seite 23 Seite 24 Seite 25 Seite 26 Current page 27 Seite 28 Seite 29 Seite 30 Seite 31
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states